Skip to content

Randomized controlled clinical study on the treatment of non-puerperal mastitis in abscess stage with TCM combined therapy based on fire needle

Randomized controlled clinical study on the treatment of non-puerperal mastitis in abscess stage with TCM combined therapy based on fire needle

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500113992
Enrollment
Unknown
Registered
2025-12-05
Start date
2022-10-18
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-puerperal mastitis

Interventions

TCM treatment group:1.Orally taken No. 2 formula for NPM of our department 2.use Fire needle to break the abscess and gently pressure out the pus
modern medicine treatment group:1.Oral broad spectrum antibiotic and / or hormones 2.The pus is extracted by puncture or drained by incision

Sponsors

China-Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Meet all of the following criteria 1.Female patients, aged 18-60 years old 2.Met the diagnostic criteria for non-puerperal mastitis 3.Were in the abscess stage with single abscess less than 3cm, the range of breast mass was no more than 2 quadrants and the mass was less than 10cm in diameter. 4.The syndrome type was consistent with the stagnation of heat in the liver meridian of traditional Chinese medicine. 5.Signed the informed consent form.

Exclusion criteria

Exclusion criteria: Those who met any of the following criteria were excluded: 1.Were intolerant to fire needling; 2.With deep breast abscess; 3.Were in the late stage of NPM ulceration; 4.Were in lactation or pregnancy; 5.Were pathologically diagnosed as breast tuberculosis; 6.Had diabetes and poor blood glucose control (fasting blood glucose> 10mmol/l); 7. The lesion is suspected to be malignant. 8.With serious acute or chronic primary diseases of the heart, liver, kidney or blood or mental system 9.Other conditions that would reduce or complicate enrollment according to the investigator's judgment, such as frequent changes in the work environment, or condition that is easy to cause loss to follow-up or poor adherence 10.Who is participating in other clinical studies.

Design outcomes

Primary

MeasureTime frame
Clinical effective rate;

Secondary

MeasureTime frame
Score of symptoms and signs;Duration of healing;Scar condition after healing;Evaluation of breast shape;Recurrence rate;TCM syndrome score;

Countries

China

Contacts

Public ContactXia Zhongyuan

China-Japan Friendship Hospital

2718421708@qq.com+86 137 0133 8757

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026